Maternal and Perinatal Outcomes in Pregnant Women with Covid-19: A Retrospective Egyptian Study

Background: Severe acute respiratory distress coronavirus 2 is the causative agent of the newly identified coronavirus disease 2019 (COVID-19) (SARS CoV-2). Infections caused by coronavirus may produce a wide spectrum of symptoms, from moderate to life-threatening conditions including viral pneumonia accompanying systemic damage. Pregnant women may be more susceptible to developing respiratory infection problems, which may increase the risk of both maternal and fetal morbidity and mortality due to the physiological and immunologic changes that occur during pregnancy.Aim of work: to assess maternal and perinatal outcomes in Egypt's isolation hospitals in relation to SARS-CoV-2 infection during pregnancy, hospitalization, and newborn survival.Patients and methods: Minia University Hospital's Obstetrics and Gynecology ward was the site of this retrospective cohort research. Between March 2020 и June 2021, 46 pregnant women who've been tested for SARS-CoV-2 were included in the research. Results: According to the distribution of trial information among the women who were evaluated, one baby was born with COVID infectious agent and four newborns required admission to the neonatal intensive care unit. Neonatal jaundice was the only minor consequence. Most patients were successfully released from the hospital, and the care of one patient was transferred to a different facility. Conclusions: COVID-19 is associated with a greater risk of mortality, mechanical ventilation, and intensive care unit hospitalization among pregnant women. Preterm delivery is common among pregnant women with Covid-19, and their babies often need care in the neonatal intensive care unit (NICU). Therefore, pregnancies with covid-19 should be considered high-risk.